Literature DB >> 21160846

Natural history of intraductal papillary mucinous neoplasia: How much do we really know?

Chad G Ball1, Thomas J Howard.   

Abstract

Information on the natural history of intraductal papillary mucinous neoplasia (IPMN) is currently inadequate due to a lack of carefully orchestrated long-term follow-up on a large cohort of patients with asymptomatic disease. Based on the available data, one can draw the conclusions that main duct IPMN is commonly associated with malignancy and an aggressive operative stance should be taken with resection being offered to most patients who are suitable operative candidates. In contrast, the majority of branch type IPMN with a diameter of less than 3 cm can be safely followed with routine surveillance imaging provided they lack the high-risk covariates of age, symptomatology, nodularity or wall thickness.

Entities:  

Keywords:  Cystic pancreatic neoplasm; Intraductal papillary mucinous neoplasia; Pancreas

Year:  2010        PMID: 21160846      PMCID: PMC2999204          DOI: 10.4240/wjgs.v2.i10.368

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  48 in total

1.  The prevalence and implications of incidental findings on ED abdominal CT scans.

Authors:  W A Messersmith; D F Brown; M J Barry
Journal:  Am J Emerg Med       Date:  2001-10       Impact factor: 2.469

2.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

Review 4.  Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature.

Authors:  C Zamora; J Sahel; D G Cantu; L Heyries; J P Bernard; C Bastid; M J Payan; I Sielezneff; L Familiari; B Sastre; M Barthet
Journal:  Am J Gastroenterol       Date:  2001-05       Impact factor: 10.864

5.  Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas.

Authors:  Michael G House; MingZhou Guo; Christine Iacobuzio-Donahue; James G Herman
Journal:  Carcinogenesis       Date:  2003-02       Impact factor: 4.944

6.  Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.

Authors:  M Sugiyama; Y Izumisato; N Abe; T Masaki; T Mori; Y Atomi
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

7.  Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.452

8.  Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography.

Authors:  Hiroyuki Irie; Kengo Yoshimitsu; Hitoshi Aibe; Tsuyoshi Tajima; Akihiro Nishie; Tomohiro Nakayama; Daisuke Kakihara; Hiroshi Honda
Journal:  J Comput Assist Tomogr       Date:  2004 Jan-Feb       Impact factor: 1.826

9.  Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?

Authors:  Keita Wada; Tadahiro Takada; Hideki Yasuda; Hodaka Amano; Masahiro Yoshida; Maki Sugimoto; Hiroshi Irie
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  4 in total

1.  Intraductal papillary mucinous neoplasm: Coming of age.

Authors:  Charles M Vollmer; Elijah Dixon
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 2.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

3.  The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm.

Authors:  David A Klibansky; Kaye M Reid-Lombardo; Stuart R Gordon; Timothy B Gardner
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-28       Impact factor: 11.382

4.  Natural history of asymptomatic pancreatic cystic neoplasms.

Authors:  Gareth Morris-Stiff; Gavin A Falk; Sricharan Chalikonda; R Matthew Walsh
Journal:  HPB (Oxford)       Date:  2012-07-23       Impact factor: 3.647

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.